Germany produces a wide range of medicines used to treat conditions such as cancer, rheumatoid arthritis, stroke, diabetes, hepatitis C, HIV and influenza, as well as vaccines against diphtheria.
This ensures short, efficient supply routes from manufacturing to patients, while pharmaceutical products bearing the “Made in Germany” hallmark are in strong demand worldwide.
To maintain this level of manufacturing excellence, product quality and supply security, MEGLA supports the pharmaceutical industry with essential, production‑accompanying IT systems.
Good Manufacturing Practice (GMP) refers to the standards that ensure the consistent and controlled manufacture of medicinal products. GMP requirements are laid down in national and international regulatory frameworks.
To obtain a manufacturing licence, pharmaceutical facilities worldwide must comply with GMP regulations.
* Cf.: German Ordinance on the Manufacture of Medicinal Products and Active Substances (AMWHV).
Find out more now!